See also this year's filing and all EDGAR filings for this company.
PDF Report 0001114220_2018_KERYX_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'REGENERX BIOPHARMACEUTICALS INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001114220')"} |
Graph
Absolute values for 0001114220, KERYX BIOPHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 141,566,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,208,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,521,000 |
| 3 | remainder_Assets | 9,577,000 |
| 4 | LiabilitiesCurrent | 45,420,000 |
| 5 | LiabilitiesNoncurrent | 894,000 |
| 6 | remainder_Liabilities | 126,653,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 99,622,000 |
| 9 | ResearchAndDevelopmentExpense | 37,679,000 |
| 10 | remainder_Expenses | 24,831,000 |
| 11 | remainder_Revenues | 60,641,000 |
| 12 | remainder_NetIncome | -61,984,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 158,872,000 |
| 1 | Liabilities | 172,967,000 |
| 2 | Expenses | 162,132,000 |
| 3 | Revenues | 60,641,000 |
| 4 | StockholdersEquity | -14,095,000 |
| 5 | NetIncome | -163,475,000 |
| 6 | ComprehensiveNetIncome | -163,475,000 |
| 7 | BaseVar | 308,298,000 |
| 8 | EconomicCapitalRatio | -1.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
